Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients

NCT01820949 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110000

Last updated 2015-09-07

No results posted yet for this study

Summary

This study will evaluate clinical outcome after the step-wise implementation of a Patient Blood Management (PBM) Program in surgical patients at 4 hospitals.

Conditions

  • Surgery

Sponsors & Collaborators

  • University Hospital Schleswig-Holstein

    collaborator OTHER
  • University Hospital, Bonn

    collaborator OTHER
  • University Hospital Muenster

    collaborator OTHER
  • Vifor Pharma

    collaborator INDUSTRY
  • B. Braun Melsungen AG

    collaborator INDUSTRY
  • CSL Behring

    collaborator INDUSTRY
  • Fresenius Kabi

    collaborator INDUSTRY
  • Johann Wolfgang Goethe University Hospital

    lead OTHER

Principal Investigators

  • Kai Zacharowski, MD, PhD, FRCA · Goethe University

  • Patrick Meybohm, MD · Goethe University

  • Erhard Seifried, MD · German Red Cross Blood Service Baden-Württemberg-Hessen, Institute for Transfusion Medicine and Immunohematology of the Goethe University Hospital, Frankfurt

  • Eva Herrmann · Institute of Biostatistics and Mathematical Modeling, Goethe University Frankfurt

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-07-31
Completion
2015-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01820949 on ClinicalTrials.gov